Phase 1 study of LX2761 in diabetes patients

Trial Profile

Phase 1 study of LX2761 in diabetes patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs LX 2761 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Nov 2017 According to a Lexicon Pharmaceuticals media release, data from this study is expected in first half of 2018.
    • 01 Aug 2017 According to a Lexicon Pharmaceuticals media release, data from this study is expected in second half of 2017.
    • 02 May 2017 According to a Lexicon Pharmaceuticals media release, the Company anticipates the release of data this year from these studies in healthy subjects and patients with T2DM.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top